Search Results - "HESSELING, A. C"

Refine Results
  1. 1

    Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis [Review article] by MANDALAKAS, A. M, DETJEN, A. K, HESSELING, A. C, BENEDETTI, A, MENZIES, D

    “…BACKGROUND: Children infected with Mycobacterium tuberculosis have significant risk of developing tuberculosis (TB) and can therefore benefit from preventive…”
    Get full text
    Journal Article
  2. 2

    Fungal diversity in the gut microbiome of young South African children by Nel Van Zyl, K, Whitelaw, A C, Hesseling, A C, Seddon, J A, Demers, A-M, Newton-Foot, M

    Published in BMC microbiology (17-08-2022)
    “…The fungal microbiome, or mycobiome, is a poorly described component of the gut ecosystem and little is known about its structure and development in children…”
    Get full text
    Journal Article
  3. 3

    High Incidence of Tuberculosis among HIV-Infected Infants: Evidence from a South African Population-Based Study Highlights the Need for Improved Tuberculosis Control Strategies by Hesseling, A. C., Cotton, M. F., Jennings, T., Whitelaw, A., Johnson, L. F., Eley, B., Roux, P., Godfrey-Faussett, P., Schaaf, H. S.

    Published in Clinical infectious diseases (01-01-2009)
    “…Background. There are limited population-based estimates of tuberculosis incidence among human immunodeficiency virus (HIV)—infected and HIV-uninfected infants…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines by Bekker, A, Schaaf, H S, Draper, H R, van der Laan, L, Murray, S, Wiesner, L, Donald, P R, McIlleron, H M, Hesseling, A C

    Published in Antimicrobial agents and chemotherapy (01-04-2016)
    “…There are limited pharmacokinetic data for use of the first-line antituberculosis drugs during infancy (<12 months of age), when drug disposition may differ…”
    Get full text
    Journal Article
  5. 5
  6. 6

    High burden of viral respiratory co-infections in a cohort of children with suspected pulmonary tuberculosis by van der Zalm, M M, Walters, E, Claassen, M, Palmer, M, Seddon, J A, Demers, A M, Shaw, M L, McCollum, E D, van Zyl, G U, Hesseling, A C

    Published in BMC infectious diseases (04-12-2020)
    “…The presentation of pulmonary tuberculosis (PTB) in young children is often clinically indistinguishable from other common respiratory illnesses, which are…”
    Get full text
    Journal Article
  7. 7

    The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era [State of the Art] by MARAIS, B. J, GIE, R. P, SCHAAF, H. S, HESSELING, A. C, OBIHARA, C. C, STARKE, J. J, ENARSON, T. D. A, DONALD, P. R, BEYERS, N

    “…The pre-chemotherapy literature documented the natural history of tuberculosis in childhood. These disease descriptions remain invaluable for guiding public…”
    Get full text
    Journal Article
  8. 8

    Bacille Calmette-Guérin Vaccine—Induced Disease in HIV-Infected and HIV-Uninfected Children by Hesseling, A. C., Rabie, H., Marais, B. J., Manders, M., Lips, M., Schaaf, H. S., Gie, R. P., Cotton, M. F., van Helden, P. D., Warren, R. M., Beyers, N.

    Published in Clinical infectious diseases (15-02-2006)
    “…Background. Bacille Calmette-Guérin (BCG)—a live, attenuated vaccine—is routinely given to neonates in settings where tuberculosis is endemic, irrespective of…”
    Get full text
    Journal Article
  9. 9

    Disseminated bacille Calmette―Guérin disease in HIV-infected South African infants by HESSELING, A. C, JOHNSON, L. F, BEYERS, N, GODFREY-FAUSSETT, P, JASPAN, H, COTTON, M. F, WHITELAW, A, SCHAAF, H. S, FINE, Pem, ELEY, B. S, MARAIS, B. J, NUTTALL, J

    Published in Bulletin of the World Health Organization (01-07-2009)
    “…To determine the population-based incidence of disseminated bacille Calmette-Guérin (BCG) disease in HIV-infected infants (aged <or= 1 year) in a setting with…”
    Get full text
    Journal Article
  10. 10

    Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection by Mandalakas, A. M., Kirchner, H. L., Lombard, C., Walzl, G., Grewal, H. M. S., Gie, R. P., Hesseling, A. C.

    “…SETTING: Cape Town, South Africa.OBJECTIVE: To develop a standardized, reliable measure of household tuberculosis (TB) exposure that considers child-specific…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetics of Ofloxacin and Levofloxacin for Prevention and Treatment of Multidrug-Resistant Tuberculosis in Children by THEE, S, GARCIA-PRATS, A. J, MCILLERON, H. M, WIESNER, L, CASTEL, S, NORMAN, J, DRAPER, H. R, VAN DER MERWE, P. L, HESSELING, A. C, SCHAAF, H. S

    Published in Antimicrobial agents and chemotherapy (01-05-2014)
    “…Limited data on fluoroquinolone pharmacokinetics and cardiac effects in children exist. Among 22 children receiving drug-resistant tuberculosis prophylaxis or…”
    Get full text
    Journal Article
  12. 12

    Ambulatory Gastric Lavages Provide Better Yields of Mycobacterium tuberculosis Than Induced Sputum in Children With Intrathoracic Tuberculosis by MUKHERJEE, Aparna, SINGH, Sarman, LODHA, Rakesh, SINGH, Varinder, HESSELING, A. C, GREWAL, Harleen M. S, KABRA, Sushil K

    Published in The Pediatric infectious disease journal (01-12-2013)
    “…To compare mycobacterial yield by induced sputum (IS) and gastric lavage (GL), performed on an ambulatory basis in children with probable intrathoracic…”
    Get full text
    Journal Article
  13. 13

    The burden of childhood tuberculosis and the accuracy of community-based surveillance data by MARAIS, B. J, HESSELING, A. C, GIE, R. P, SCHAAF, H. S, BEYERS, N

    “…BACKGROUND: Inadequate surveillance and diagnostic difficulties compromise the quality of epidemiological data on childhood tuberculosis (TB).OBJECTIVE: To…”
    Get full text
    Journal Article
  14. 14

    Highly discordant T cell responses in individuals with recent exposure to household tuberculosis by Hesseling, A C, Mandalakas, A M, Kirchner, H L, Chegou, N N, Marais, B J, Stanley, K, Zhu, X, Black, G, Beyers, N, Walzl, G

    Published in Thorax (01-10-2009)
    “…There are limited data comparing interferon-gamma release assays (IGRAs) for the detection of Mycobacterium tuberculosis infection in highly endemic settings…”
    Get more information
    Journal Article
  15. 15

    Pharmacokinetics of Isoniazid in Low-Birth-Weight and Premature Infants by BEKKER, A, SCHAAF, H. S, SEIFART, H. I, DRAPER, H. R, WERELY, C. J, COTTON, M. F, HESSELING, A. C

    Published in Antimicrobial agents and chemotherapy (01-04-2014)
    “…Isoniazid (INH) is recommended for use as posttuberculosis exposure preventive therapy in children. However, no pharmacokinetic data are available for INH…”
    Get full text
    Journal Article
  16. 16

    Pharmacokinetics of Ethionamide in Children by THEE, S, SEIFART, H. I, ROSENKRANZ, B, HESSELING, A. C, MAGDORF, K, DONALD, P. R, SCHAAF, H. S

    Published in Antimicrobial Agents and Chemotherapy (01-10-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa by Seddon, J. A., Hesseling, A. C., Marais, B. J., Jordaan, A., Victor, T., Schaaf, H. S.

    “…SETTING: Tygerberg Children's Hospital, Cape Town, South Africa.OBJECTIVE: To determine the prevalence and trend of drug resistance and human immunodeficiency…”
    Get full text
    Journal Article
  18. 18

    Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children by Rose, P. C., Hallbauer, U. M., Seddon, J. A., Hesseling, A. C., Schaaf, H. S.

    “…BACKGROUND: Treatment options for drug-resistant tuberculosis (DR-TB) are limited. Linezolid has been successfully used to treat DR-TB in adults, but there are…”
    Get full text
    Journal Article
  19. 19

    High level of discordant IGRA results in HIV-infected adults and children by MANDALAKAS, A. M, HESSELING, A. C, CHEGOU, N. N, KIRCHNER, H. L, ZHU, X, MARAIS, B. J, BLACK, G. F, BEYERS, N, WALZL, G

    “…SETTING: Tygerberg district, Western Cape Province, South Africa.OBJECTIVE: To measure the agreement of two interferon-gamma release assays (IGRAs) and the…”
    Get full text
    Journal Article
  20. 20

    The spectrum of disease in children treated for tuberculosis in a highly endemic area [Unresolved Issues] by MARAIS, B. J, GIE, R. P, SCHAAF, H. S, HESSELING, A. C, ENARSON, D. A, BEYERS, N

    “…BACKGROUND: Children contribute a substantial proportion of the global tuberculosis (TB) caseload, particularly in endemic areas, where little is known about…”
    Get full text
    Journal Article